Colchicine for treatment of acute or recurrent pericarditis

In The Lancet, Massimo Imazio and colleagues report on the Colchicine for Recurrent Pericarditis 2 (CORP-2) trial for treatment of multiple recurrences of pericarditis. This study answers one of the last questions about the role of colchicine for the treatment of pericarditis. The findings should he...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2014-06, Vol.383 (9936), p.2193-2194
1. Verfasser: Cacoub, Patrice P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In The Lancet, Massimo Imazio and colleagues report on the Colchicine for Recurrent Pericarditis 2 (CORP-2) trial for treatment of multiple recurrences of pericarditis. This study answers one of the last questions about the role of colchicine for the treatment of pericarditis. The findings should help convince clinicians of the major role of colchicine in the treatment of patients with either acute or recurrent (even multiple) pericarditis, and should change clinical practice.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(14)60113-6